Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124913) titled 'Genetic biomarkers for diagnosis and prognosis in glioma patients based on a large, prospective, disease-specific cohort' on May 19.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
Condition:
Glioma
Intervention:
Gliomas:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-31
Target Sample Size: Gliomas:500;Non-gliomas:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=322646
Disclaimer: Curated by HT Syndication....